Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.52 SEK | -8.13% |
|
+50.02% | +50.02% |
Jul. 01 | Active Biotech Enters Agreement for A Clinical Study of Tasquinimod in Myelofibrosis | CI |
May. 22 | Active Biotech Secures Exclusive Licensing Rights to Multiple Myeloma Drug | MT |
Performance
1 day | -8.13% | ||
1 week | +50.02% | ||
Current month | +50.02% | ||
1 month | +50.02% | ||
3 months | +50.02% | ||
6 months | +50.02% | ||
Current year | +50.02% | ||
1 year | +50.02% | ||
3 years | +1.10% | ||
5 years | -57.85% | ||
10 years | -95.17% |
Volumes
marketsBasic data
Highs and lows
![Extreme 1.0135](/images/extremecours_fleche.png)
![Extreme 1.0135](/images/extremecours_fleche.png)
![Extreme 1.0135](/images/extremecours_fleche.png)
Indicators
Sector Comparison - Bio Therapeutic Drugs
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
-8.13% | +50.02% | +50.02% | +50.02% | 17.91M | ||
-0.69% | +2.99% | +20.12% | +41.23% | 127B | ||
+1.83% | +6.36% | +25.25% | +53.12% | 117B | ||
+0.33% | +7.10% | +25.56% | +27.45% | 27.77B | ||
+0.30% | +6.07% | -19.51% | -22.06% | 20.44B | ||
+2.64% | +5.16% | -14.36% | -28.39% | 16.62B | ||
+1.11% | +3.49% | -15.63% | -20.77% | 15.92B | ||
-0.05% | +2.05% | -46.67% | -38.80% | 14.94B | ||
+0.63% | +6.00% | +11.89% | +51.63% | 14.74B | ||
0.00% | +0.25% | +57.74% | +40.86% | 14.38B | ||
-0.42% | +9.59% | +147.53% | +277.70% | 12.42B | ||
-0.32% | -2.58% | +147.72% | +301.96% | 9.55B | ||
+0.52% | +5.91% | +31.19% | +72.11% | 8.92B | ||
+12.10% | +17.43% | -9.64% | -21.92% | 8.84B | ||
+1.75% | +1.67% | +9.63% | +59.52% | 7.78B | ||
-1.80% | -1.59% | -4.93% | +32.60% | 7.48B | ||
Average | +0.61% | +4.85% | +25.99% | +54.77% | ||
Weighted average by Cap. | +0.74% | +4.83% | +21.50% | +45.33% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2022 | -32.61% | ||
2021 | -33.16% | ||
2020 | -37.63% | ||
2019 | +0.38% | ||
2018 | +100.78% | ||
2017 | -82.58% | ||
2016 | -3.75% | ||
2015 | -43.82% | ||
2014 | -73.52% | ||
2013 | +18.60% | ||
2012 | +307.41% | ||
2011 | -91.09% | ||
2010 | +216.02% | ||
2009 | +13.44% | ||
2008 | -24.27% |
- Stock Market
- Equities
- ACTI Stock
- 0GQU Stock
- Quotes Active Biotech AB